Longevity Health Holdings, Inc. (OTCPK: XAGE)
Health Care · Biotechnology · US
$0.12
-20.88% today · -83.5% 1Y
Longevity Health Holdings, Inc. (OTCPK: XAGE) operates in the Biotechnology industry within the Health Care sector. The company is valued at $305.70K and employs 10 people.
Over the last twelve months the share price has lost 83.5%, trading between 0.12 and 0.83.
Tweenvest scores Longevity Health Holdings, Inc. across four factors: quality 26/100, value 47/100. Its strongest factor is value.
XAGE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $305.70K
- Revenue (TTM)
- $1.69M
- P/E
- —
- EPS
- -3.46
- Dividend yield
- —
- Beta (5Y)
- 0.43
- 52-week high
- $0.83
- 52-week low
- $0.12
- Avg volume (3M)
- —
- Shares outstanding
- 2.48M
- Employees
- 10
- Next earnings
- —
About Longevity Health Holdings, Inc.
Longevity Health Holdings Inc. specializes in creating plasma-based bioactive materials (PBMs) aimed at fostering tissue regeneration and repair in response to injury, illness, and the natural aging process. The company's primary investigational product is CT-101, which acts as a powerful accelerant for bone healing in diverse applications such as tibia fracture recovery, foot/ankle and spinal fusions, serving as a dental bone graft substitute, and filling bone voids. Additionally, CT-101 functions as a tissue healing accelerant, offering potential for treating androgenetic alopecia and persistent chronic wounds. Established in 2008, the company maintains its headquarters in Pittsburgh, Pennsylvania.
- ISIN
- US1429221294
- Founded
- 2008
- Listed since
- Sep 23, 2021
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Actavia Life Sciences, Inc.OTCPK: RASP | $385.91K | $— | — |
| Waverley Pharma Inc.TSXV: WAVE | $385.12K | CA$0.01 | -33.33% |
| Paion AGDB: PA8K | $369.33K | €0.05 | -9.80% |
| Nextel Medical Corp.OTCPK: MAJI | $305.95K | $0.00 | -25.00% |
| ChitogenX Inc.CNSX: CHGX | $303.81K | CA$— | — |
| bioXXmed AGDB: T5O | $275.38K | €0.90 | -16.67% |
| NKGen Biotech, Inc.OTCPK: NKGN | $274.26K | $0.00 | -82.50% |
| Albert Labs International Corp.CNSX: ABRT | $271.79K | CA$— | — |
Figures last refreshed Oct 4, 2026.